Skip to content

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

RKDA Arcadia Biosciences, Inc.
$0.29 -0.35% 0.00
Notify me if price changes either direction
Interactive Brokers Logotype

Buy RKDA stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 691.4K
Enterprise value -3483665
Trailing PE -0.16473683348873
Forward PE -0.22515625
PEG Ratio 0.0045901032237031
Enterprise to EBITDA 0.919
Enterprise to revenue -0.734
Price to book MRQ 0.99379313
Price to sales TTM 0.14629878

Financials

Fiscal Year Ends 2025-12-31
Most Recent Quarter (MRQ) 2026-06-30
Revenue (TTM) 4.7M
EBITDA -3792000
Diluted EPS TTM -4.54
Total Cash (MRQ) 4.2M
Current ratio (MRQ) 3.487
Operating Cash Flow (TTM) -2536000

RKDA trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent RKDA News

Home

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.